Literature DB >> 7563329

Changing age incidence and pathological types of schistosoma-associated bladder carcinoma.

M M Koraitim1, N E Metwalli, M A Atta, A A el-Sadr.   

Abstract

PURPOSE: The changes in certain characteristic features of schistosoma-associated bladder carcinoma are determined.
MATERIALS AND METHODS: A retrospective study was done of patients with schistosoma-associated bladder carcinoma treated between 1962 and 1967, and between 1987 and 1992.
RESULTS: Mean patient age increased from 47 +/- 13.6 to 53 +/- 12.2 years and the male-to-female ratio changed from 7.8:1 to 4.9:1. Tumors showed a decreased incidence of nodular (58.7% versus 83.4%) and squamous (54% versus 65.8%) cell types, and an increased incidence of papillary (34.8% versus 4.3%) and transitional (42% versus 31%) cell types. All changes were statistically significant (p < 0.05) and paralleled by an increased incidence of low degree schistosomal infestation from 18.6 to 47.8% (p < 0.05).
CONCLUSIONS: The shift in age incidence and pathological findings towards those of nonschistosomal cases could conceivably be attributed to the increased incidence of low infestation in recent years. The change in male-to-female ratio is probably due to more exposure of women to schistosomal infestation than has occurred previously.

Entities:  

Mesh:

Year:  1995        PMID: 7563329

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Urinary bladder cancer risk factors in Egypt: a multicenter case-control study.

Authors:  Yun-Ling Zheng; Sania Amr; Doa'a A Saleh; Chiranjeev Dash; Sameera Ezzat; Nabiel N Mikhail; Iman Gouda; Iman Loay; Tamer Hifnawy; Mohamed Abdel-Hamid; Hussein Khaled; Beverly Wolpert; Mohamed A Abdel-Aziz; Christopher A Loffredo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-06       Impact factor: 4.254

Review 2.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

3.  Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer.

Authors:  Farha A El-Chennawi; Fatma A Auf; Shereen S Metwally; Youssef M Mosaad; Atallah A Shaaban; Mahmoud Abdo El-Baz; Ziyad E Tawhid; Zakaria F Lotfy
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

Review 4.  Relationship between schistosomiasis and bladder cancer.

Authors:  M H Mostafa; S A Sheweita; P J O'Connor
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

5.  Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer.

Authors:  Olfat Ali Hammam; Ahmed A Aziz; Mamdouh S Roshdy; Ahmed M Abdel Hadi
Journal:  Medscape J Med       Date:  2008-03-11

6.  Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer.

Authors:  Cydney Urbanek; Steve Goodison; Myron Chang; Stacy Porvasnik; Noburo Sakamoto; Chen-zhong Li; Susan K Boehlein; Charles J Rosser
Journal:  BMC Cancer       Date:  2011-06-10       Impact factor: 4.430

7.  Hematobium schistosomiasis control for health management of labor force generation at Nkhotakota and Lilongwe in the Republic of Malawi-assumed to be related to occupational risk.

Authors:  Nobuyuki Mishima; Samuel K Jemu; Tomoaki Kuroda; Koichiro Tabuchi; Andrew W Darcy; Takaki Shimono; Pheophet Lamaningao; Mari Miyake; Seiji Kanda; Susan Ng'ambi; Yoshihiro Komai; Hirofumi Maeba; Hiroyuki Amano; Toshimasa Nishiyama
Journal:  Trop Med Health       Date:  2019-05-02

8.  Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells.

Authors:  Kazunori Namiki; Steve Goodison; Stacy Porvasnik; Robert W Allan; Kenneth A Iczkowski; Cydney Urbanek; Leticia Reyes; Noboru Sakamoto; Charles J Rosser
Journal:  PLoS One       Date:  2009-09-01       Impact factor: 3.240

9.  Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients.

Authors:  Peter Fabian Rambau; Philipo L Chalya; Kahima Jackson
Journal:  Infect Agent Cancer       Date:  2013-05-24       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.